Dr. Jan Kimpen serves as Philips’ first Chief Medical Officer. In this executive role, Dr. Kimpen supports the company’s strategic focus on the HealthTech market. Adding a wealth of knowledge and medical experience to Philips’ senior management team, Dr. Kimpen, joins Philips from the University Medical Center Utrecht (UMC Utrecht) in the Netherlands, where he was Chairman of the Executive Board.
Jan Kimpen (Belgian, 1958) joined UMC Utrecht, one of the largest healthcare organizations in the Netherlands, in 1997 and became President of the Board in 2009. At UMC Utrecht, Dr. Kimpen strengthened ties with the world-renowned Netherlands Cancer Institute at the Antoni van Leeuwenhoek Hospital (NKI-AVL) and the Netherlands Pediatric Oncology Center. He has been the driving force behind partnerships with Philips and Eindhoven University of Technology, where he is a member of the strategic advisory board Health.
Kees Wesdorp joined Philips in 2017 to lead Philips’ largest business group, Diagnostic Imaging (DI). DI includes Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Advanced Molecular Imaging (AMI) and Diagnostic X-Ray (DXR), which includes Mammography.
Kees brings a wealth of scientific and corporate experience to Philips. Prior to joining Philips, Kees was an executive vice president at Bain Capital focused on driving transformation in selected Bain Capital portfolio companies. Before Bain Capital, Kees worked for NXP Semiconductors and has been involved in the transformation of NXP in a variety of operational and functional roles in the business. Prior to joining NXP, he was a consultant at McKinsey & Company on strategic and operational issues across a wide-variety of industries and clients. He has worked with the imaging technology during his Ph.D. in atomic physics.
Rethinking radiology design and imaging centers with a patient-first approach can lead to meaningful strides in accomplishing the overall goals in value-based care.